Fei Yu

5PUBLICATIONS
19CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Regenerative medicine (incl. stem cells)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 20, 2026
CDS2 Drives Tumor Progression in Epithelial Ovarian Cancer via the PI3K/AKT Pathway.

|Sep 12, 2025
Specific loading of oncolytic VSV on CAR enhances CAR-T cell signaling and antitumor activity.

Fan Xing, Xuemei Wang, Zeying Li

|Nov 12, 2024
ICOS-expressing CAR-T cells mediate durable eradication of triple-negative breast cancer and metastasis.

Lixue Cao, Haojie Peng, Yanzhen Chen

|Jan 25, 2024
Generation of a new therapeutic D-peptide that induces the differentiation of acute myeloid leukemia cells through A TLR-2 signaling pathway.

Fei Yu, Yingshi Chen, Mo Zhou

|Nov 08, 2021
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) sensitize melanoma cells to MEK inhibition and inhibit metastasis and relapse by inducing degradation of AXL.

Yingshi Chen, Yiwen Zhang, Siqi Chen

Pageof 1

Frequent Collaborators

3 joint publications

Hui Zhang

1 joint publications

Xiancai Ma

1 joint publications

Lixue Cao

1 joint publications

Xinxin Chen